AIA Group’s Bio-Techne TECH Stock Holding History

AIA Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,734	Closed	-$468K	–	339
2023 Q2	$468K	Buy	+5,734	New	+$461K	0.02%	252
2022 Q2	–	Sell	-1,672	Closed	-$181K	–	545
2022 Q1	$181K	Buy	1,672 +660	+65%	+$68.1K	0.01%	385
2021 Q4	$131K	Buy	+1,012	New	+$124K	0.01%	372

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIA Group's TECH Position: Q3 2023 in Review

AIA Group sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 5,734 shares — an estimated $468K sold.

AIA Group first reported a position in TECH in Q4 2021 and held it in 3 quarters. The position peaked at $468K in Q2 2023. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

AIA Group reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
AIA Group sold 5,734 Bio-Techne shares in Q3 2023, an estimated $468K.
AIA Group first reported a position in Bio-Techne in Q4 2021 and held it in 3 quarters.
AIA Group's Bio-Techne position peaked at $468K in Q2 2023.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on AIA Group's 13F filing for Q3 2023, filed 1 Nov 2023.